NEW YORK – Shares of Lumber Liquidators slumped 5 percent in volatile premarket trading Thursday before the company, which has been battered by reports of unsafe products, provides investors with an update about its business. Continue …
PITTSBURGH (CNNMoney.com) -- Companies that develop drugs using embryonic stem cell research could soon enter a bold ... The analysts interview for this story do not own stock in the companies mentioned here, and their firms have not …
Despite the best efforts by policymakers to stem the bleeding, Chinese stocks fell heavily in ... The CSI 300 and tech-heavy ChiNext indices declined by a similar margin. China’s stock market has become increasingly volatile with some …
ENERGY shares helped pull the Standard and Poor's 500-stock index higher, as an improving outlook for the sector sent it higher on a day heavy with merger and acquisition activity. The S&P 500-stock gained one point, or 0.1 per cent, to …
U.S. small- and mid-cap stocks continued to advance in spite of the geopolitical tensions on Tuesday, after it was reported that the Turkish military shot down a Russian fighter jet after it allegedly violated Turkish airspace. This is the first time …
Would you spend $4,000 to store your stem cells? A Boca Raton start-up is banking on the potential of these tiny powerhouses and hoping the public will catch on too. Doctors agree that stem cells are the future of medicine but new …
London indices rose as investors, many of them overseas money managers, piled in to seek bargain buys following the recent equities sell-off and a slump in the value of the pound. At 1.52pm BST on Tuesday (28 June), the blue-chip FTSE …
SAN FRANCISCO (Reuters) -- Twitter Chief Executive Jack Dorsey's novel move to give a third of his company stock to an employee equity pool is a smart gesture to restore confidence in a company that lost its way, according to recruiting …
And he believes that growth will spur stem cell stock market caps from a total of $1.7 billion last year to between $22 billion and $49 billion over the next 10 years. But Young cautions it won't be a straight line up. There's been a stem cell …